| Ytd | -24.52% | |
| 1y | -47.77% |
| Open | 1.22 | Prev Close | 1.23 | Low | 1.17 | High | 1.22 | Mkt Cap | 131.76M |
| Vol | 285.42K | Avg Vol | 1.22M | EPS | -0.34 | P/E | -3.62 | Forward P/E | -10.41 |
| Beta | 1.47 | Short Ratio | 4.08 | Inst. Own | 70.20% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 1.17 | 200-d Avg | 1.19 | 1yr Est | 8.67 |
MXCT News
ROCKVILLE, Md., July 21, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engin
ROCKVILLE, Md., July 15, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-eng
Gainers Vicore Pharma Holding (NASDAQ:VCRE) stock rose 149.8% to $42.47 during Monday's after-m
ROCKVILLE, Md. & CHICAGO--(BUSINESS WIRE)-- #BioTechNews--VectorBuilder, a global leader in gene del
(Editor’s note: The future prices of benchmark tracking ETFs, and the headline, the lede and the eco
US stock futures mixed, Cisco and MaxCyte report positive earnings, Alibaba and Vishay to release re
MaxCyte, Inc. (MXCT) Q1 2026 Earnings Call Transcript
MaxCyte NASDAQ: MXCT reported lower first-quarter revenue compared with the prior year, as managemen
MaxCyte, Inc. (MXCT) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Es
First quarter 2026 total revenue of $9.7 million, including $6.2 million of core revenue and $3.4 mi
ROCKVILLE, Md., April 29, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-en
MaxCyte, Inc. (NASDAQ: MXCT - Get Free Report) has been assigned a consensus rating of "Hold" from t
ROCKVILLE, Md., March 31, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engi
MaxCyte (NASDAQ: MXCT) executives told investors the company made "meaningful progress" in 2025 desp
MaxCyte, Inc. (MXCT) Q4 2025 Earnings Call Transcript
MaxCyte, Inc. (MXCT) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Es
Fourth quarter 2025 total revenue of $7.3 million at the top of the range of previous preliminary an
ROCKVILLE, Md., March 23, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engi
ROCKVILLE, Md., Feb. 24, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-eng
ROCKVILLE, Md., Feb. 23, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-eng
ROCKVILLE, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc. , (Nasdaq: MXCT; LSE: MXCT), a leadi
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufac
MaxCyte, Inc. ( MXCT ) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Mahe
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for it
On Thursday, 369 companies hit new 52-week lows.
On Tuesday, 647 companies set new 52-week lows.
During the session on Thursday, 461 stocks hit new 52-week lows.
On Tuesday, 951 companies hit new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.
On Wednesday, 807 companies reached new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
During Thursday, 166 stocks hit new 52-week lows.
Tuesday's session saw 729 companies set new 52-week lows.
On Friday, 209 companies set new 52-week lows.